Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...
EMA recommends Kygevvi for rare thymidine kinase 2 deficiency. It is the first authorized treatment for this disease.
The EMA recommends Rezurock (belumosudil) for chronic graft-versus-host disease. It meets unmet needs via conditional ...
FDA Commissioner Marty Makary, M.D., M.P.H., characterized the program as a “bold step” to bring manufacturing back to the US ...
Financial support and mentorship are crucial for encouraging women to consider STEM careers, bridging the gap in ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Vetter's €1.5 billion investment focuses on expanding commercial and clinical production, with a new plant in Saarlouis, Germany, creating up to 2,000 jobs. The US expansion prioritizes clinical ...
Government shutdowns lead to decreased predictability, causing delays in new submissions and manufacturing changes. Key risk ...
Ultimately, the interview underscores a critical transition period for the industry. While tariffs present a unique hurdle ...
Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...
Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...
February 11 is the International Day of Women and Girls in Science (1). This day focuses on the gender gap in science, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results